# AI Health Assistant and Type 2 Diabetes

Study · id `cardio:ct-nct05539066` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05539066](<https://clinicaltrials.gov/study/NCT05539066>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05539066

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 196 participants.

## Technical summary

Registry record NCT05539066. Randomized; no masking; primary purpose treatment. Start 2022-10-01 (anticipated); primary completion 2024-09-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 196 participants (planned count; ClinicalTrials.gov record NCT05539066, source copy `cardio:ctgov-nct05539066-2022-09-14`, retrieved 2026-10-26)
- Planned start: 2022-10-01 (anticipated) (ClinicalTrials.gov record NCT05539066, source copy `cardio:ctgov-nct05539066-2022-09-14`, retrieved 2026-10-26)
- Primary completion: 2024-09-30 (anticipated) (ClinicalTrials.gov record NCT05539066, source copy `cardio:ctgov-nct05539066-2022-09-14`, retrieved 2026-10-26)
- Completion: 2024-09-30 (anticipated) (ClinicalTrials.gov record NCT05539066, source copy `cardio:ctgov-nct05539066-2022-09-14`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05539066-2022-09-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: AI Health Assistant and Type 2 Diabetes
- Condition: Health Behavior
- Condition: Type2 Diabetes Mellitus
- Intervention (Device): AI health assistant
- Lead sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (`cardio:org-shanghai-general-hospital-shanghai-jiao-tong-university-237209`)

## Provenance

Content hash: 1344cef5b2246d8e70a560454d8b18d71880a5bf2d1948bf1c094509817433b6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
